Theranostics is advancing personalized Cancer Care. In this session, experts share how advanced PET/SPECT imaging and quantitative methods are impacting radiology - improving patient selection, guiding therapy and sharpening response assessment. They'll highlight practical challenges, pathway integration and what radiologists need to know as imaging-led precision therapy accelerates across the globe.
TBD
Ambros J. Beer, Ulm / Germany
Meinrad Johannes Beer, Ulm / Germany